June 30, 2023 02:21 PM EDTUpdated 03:59 PM
People

Fol­low­ing con­tro­ver­sy, new Bio­gen di­rec­tor Su­san Langer won fewest votes from share­hold­ers

Kyle LaHucik

Senior Reporter

Af­ter her con­tro­ver­sial nom­i­na­tion by Alex Den­ner to Bio­gen’s board, Su­san Langer was elect­ed this week with few­er votes than any oth­er mem­ber of the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times